|
Volumn 102, Issue 3, 2014, Pages 720-727
|
Enclomiphene citrate stimulates testosterone production while preventing oligospermia: A randomized phase II clinical trial comparing topical testosterone
|
Author keywords
hormones; male infertility; semen; Testosterone; testosterone replacement therapy
|
Indexed keywords
ANDROSTANOLONE;
ENCLOMIFENE CITRATE;
FOLLITROPIN;
LUTEINIZING HORMONE;
PLACEBO;
SEX HORMONE BINDING GLOBULIN;
TESTOSTERONE;
ADULT;
ARTICLE;
CELL STRUCTURE;
CONTROLLED STUDY;
DRUG EFFECT;
FOLLITROPIN BLOOD LEVEL;
HUMAN;
HYPOGONADISM;
LUTEINIZING HORMONE BLOOD LEVEL;
MALE;
MALE GENITAL TRACT PARAMETERS;
MIDDLE AGED;
MORNING DOSAGE;
MULTICENTER STUDY;
OLIGOSPERMIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SEMEN ANALYSIS;
SPERMATOZOON COUNT;
SPERMATOZOON DENSITY;
SPERMATOZOON MOTILITY;
TESTOSTERONE BLOOD LEVEL;
TOPICAL TREATMENT;
HORMONES;
MALE INFERTILITY;
SEMEN;
TESTOSTERONE;
TESTOSTERONE REPLACEMENT THERAPY;
ADMINISTRATION, ORAL;
ADMINISTRATION, TOPICAL;
ADULT;
ENCLOMIPHENE;
ESTRADIOL;
HUMANS;
HYPOGONADISM;
LUTEINIZING HORMONE;
MALE;
MIDDLE AGED;
OLIGOSPERMIA;
SEX HORMONE-BINDING GLOBULIN;
TESTOSTERONE;
UP-REGULATION;
|
EID: 84906934149
PISSN: 00150282
EISSN: 15565653
Source Type: Journal
DOI: 10.1016/j.fertnstert.2014.06.004 Document Type: Article |
Times cited : (52)
|
References (12)
|